4-hydroxyclomiphene has been researched along with ici 164384 in 1 studies
| Studies (4-hydroxyclomiphene) | Trials (4-hydroxyclomiphene) | Recent Studies (post-2010) (4-hydroxyclomiphene) | Studies (ici 164384) | Trials (ici 164384) | Recent Studies (post-2010) (ici 164384) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 234 | 0 | 2 |
| Protein | Taxonomy | 4-hydroxyclomiphene (IC50) | ici 164384 (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musgrove, EA; Sutherland, RL; Wakeling, AE | 1 |
1 other study(ies) available for 4-hydroxyclomiphene and ici 164384
| Article | Year |
|---|---|
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Clomiphene; DNA; Estradiol; Estrogen Antagonists; Female; Humans; Imidazoles; Polyunsaturated Alkamides; Tumor Cells, Cultured | 1989 |